Li Lab:news: Difference between revisions
Wei Li Bcm (talk | contribs) No edit summary |
Wei Li Bcm (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
{{Template:Li Lab}} | {{Template:Li Lab}} | ||
. 12/2010: Liguo's fly RNA-seq paper was published in Genome Research. | |||
. 10/2010: A Texas CPRIT grant was funded. We will work with Dr. Goodell at BCM to understand DNA Methylgransferase 3B in normal and malignant hematopoiesis. | |||
. 08/2010: Our Pilot Project was funded by a NIH Stem Cell P01 Grant. | |||
. 07/2010: The DNA methylation platform comparision paper was accepted to Nature Biotechnology. | |||
. 06/2010: Hao Zhao will join us as a '''postdoc fellow'''. Hao has a PhD in Computer Science from City University of Hong Kong. Welcome! | . 06/2010: Hao Zhao will join us as a '''postdoc fellow'''. Hao has a PhD in Computer Science from City University of Hong Kong. Welcome! | ||
Revision as of 09:38, 5 June 2012
. 12/2010: Liguo's fly RNA-seq paper was published in Genome Research.
. 10/2010: A Texas CPRIT grant was funded. We will work with Dr. Goodell at BCM to understand DNA Methylgransferase 3B in normal and malignant hematopoiesis.
. 08/2010: Our Pilot Project was funded by a NIH Stem Cell P01 Grant.
. 07/2010: The DNA methylation platform comparision paper was accepted to Nature Biotechnology.
. 06/2010: Hao Zhao will join us as a postdoc fellow. Hao has a PhD in Computer Science from City University of Hong Kong. Welcome!
. 05/2010: Our paper titled "Histone modifications and chromatin organization in prostate cancer" has been accepted by Epigenomics.
. 01/2010: A Texas CPRIT grant has been funded. We will use ChIP-seq and RNA-seq to analyze Androgen Receptor (AR) function in Prostate Cancer with Dr. Weigel at BCM.
. 01/2010: Wei Li is an invited speaker in the American Association for Cancer Research (AACR) Special Conference on Cancer Epigenetics at Puerto Rico.
. 01/2010: Deqiang Sun will join us as a postdoc fellow. Deqiang has a PhD in Condensed Matter Physics from Texas A&M University. Welcome!
. 12/2009: Dr.Bert O'Malley's SRC-3 ChIP-seq paper has been accepted by Molecular Endocrinology. Liguo and Wei are co-authors on the paper.
. 12/2009: Liguo's RNA-seq methodology paper has been accepted by PLoS ONE. Congratulations Liguo!
. 11/2009: Wei Li received a New Investigator Award from the Department of Defense (DOD) Prostate Cancer Research Program (PCRP). Cheers!
. 11/2009: Wei Li gave a Keynote Presentation at the Symposium on Advances in Cell Signaling, Cancer Prevention and Therapy at South Padre Island, Texas.
. 09/2009: A prestigious NIH Challenge grant has been funded. We will use ChIP-seq to analyze RXRa binding in mouse liver with Dr. Karpen at Texas Children's Hospital.
. 09/2009: A two-year $2.5 million NIH Grand Opportunity (GO) grant has been funded. We will study aging epigenomics with Drs. Darlington and Goodell at BCM.
. 09/2009: A prestigious NIH Challenge grant has been funded. We will use RNA-seq to characterize patient cardiac progenitors with Dr. Pu at Harvard Medical School.
. 06/2009: Yuanxin's Bisulfite Sequence Mapping paper has been accepted by BMC Bioinformatics. Congratulations Yuanxin!
. 06/2009: Kaifu Chen has accepted our postdoc offer. Kaifu has a PhD in Genomics and Bioinformatics from Beijing Institute of Genomics, Chinese Academy of Sciences. Welcome!
. 03/2009: Wei's paper titled 'Reprogrammed Androgen Receptor Function in Androgen-Independent Prostate Cancer' has been accepted by Cell.
. 03/2009: Cancer Epigenomics Workshop Please join us on May 2nd 2009 at MD Anderson Cancer Center. This meeting is organized by Steffi Oesterreich, Wei Li and Jean-Pierre Issa.